Filing Details

Accession Number:
0001209191-10-015962
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-10 12:00:00
Reporting Period:
2010-03-10
Filing Date:
2010-03-10
Accepted Time:
2010-03-10 16:02:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1176268 Phd Sandra Panem 15 Skyline Drive
Hawthorne NY 10532
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-03-10 60,000 $34.00 360,846 No 4 S Indirect Cross Atlantic
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Cross Atlantic
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,630 Direct
Footnotes
  1. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $34.000 to $34.030 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  2. Includes 309,188 shares beneficially owned by Cross Atlantic Partners IV, K/S and 51,658 shares owned by Nordea Bank Danmark, A/S. Sandra Panem, PhD, is a partner of Cross Atlantic Partners and exercises voting and investment power over these shares. Dr. Panem disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.